TGTGInsighttelegram intelligenceLIVE / telegram public index
← Find Blog👁发现博客

TGINSIGHT SIMILAR POSTS

查找相似内容

Source channel @FindBlog · Post #521 · 10月9日

静态网站悖论 个人网站的两种不同实现方式:一种是复杂的内容管理系统(CMS),另一种是简单的静态 HTML 文件。文章指出,尽管大多数普通用户倾向于使用复杂的解决方案(如 WordPress),但实际上,只有少数专业软件工程师能够选择更简单的静态网站。 via HackerNews 2024 10 09 前两天刚好听朋友说 square space 已经涨到了近乎搞笑的 $25 月费,做不用来盈利的个人博客实在难以 justify。这篇文章中吐槽得很在点子上: normal users are stuck with a bunch of greedy clowns that make them pay for every little thing, all while wasting ungodly amounts of computational power to render what could have been a static website in 99% of cases. 普通用户被困在了一群屁大点功能都要收费的贪婪小丑手里,与此同时浪费着人神共愤额度的算力来渲染 99% 的情况下都可以作为静态的网站。 当然原文中说的“只有少数专业软件工程师才能选择更简单的静态网站”略微夸张并不认同,因为静态站至少是比 self-host 的动态 CMS 少太多维护了。我的 backlog 里也一直躺了篇安利新手用静态站并拉踩 WP 的文,不过网上这种文已经有无数了也还是拦不住前赴后继往各种 CMS 的坑里冲的新手,觉得写了又有什么意义呢就还搁着没写。(当然迟早会像以前反复造的无数轮子一样被废话欲战胜的 but not today) #indieblog#newletter

Results

找到 1 条相似帖子

搜索 #floodbase

当前筛选 #floodbase清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 2025/02/26 13:00

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement